IMI – Clinical management guidelines report

Gifford, KL; Richdale, K; Kang, P; Aller, TA; Lam, CS; Liu, YM; Michaud, L; Mulder, J; Orr, JB; Rose, KA; Saunders, KJ; Seidel, D; Tideman, JWL; Sankaridurg, P

IMI – Clinical management guidelines report

Gifford, KL Richdale, K Kang, P Aller, TA Lam, CS Liu, YM Michaud, L Mulder, J Orr, JB Rose, KA

Saunders, KJ Seidel, D Tideman, JWL Sankaridurg, P

Permalink

Publication Type:: Journal Article
Citation:: Investigative Ophthalmology and Visual Science, 2019, 60 pp. M184 - M203
Issue Date:: 2019-02-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published VersionAdobe PDF (998.12 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Gifford, KL	en_US
dc.contributor.author	Richdale, K	en_US
dc.contributor.author	Kang, P	en_US
dc.contributor.author	Aller, TA	en_US
dc.contributor.author	Lam, CS	en_US
dc.contributor.author	Liu, YM	en_US
dc.contributor.author	Michaud, L	en_US
dc.contributor.author	Mulder, J	en_US
dc.contributor.author	Orr, JB	en_US
dc.contributor.author	Rose, KA https://orcid.org/0000-0003-2851-4145	en_US
dc.contributor.author	Saunders, KJ	en_US
dc.contributor.author	Seidel, D	en_US
dc.contributor.author	Tideman, JWL	en_US
dc.contributor.author	Sankaridurg, P	en_US
dc.date.issued	2019-02-01	en_US
dc.identifier.citation	Investigative Ophthalmology and Visual Science, 2019, 60 pp. M184 - M203	en_US
dc.identifier.issn	0146-0404	en_US
dc.identifier.uri	http://hdl.handle.net/10453/135444
dc.description.abstract	© 2019 The Authors. Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.	en_US
dc.relation	http://purl.org/au-research/grants/nhmrc/GNT1034329
dc.relation	http://purl.org/au-research/grants/nhmrc/NHMRC APP 1121979
dc.relation.ispartof	Investigative Ophthalmology and Visual Science	en_US
dc.relation.isbasedon	10.1167/iovs.18-25977	en_US
dc.subject.classification	Ophthalmology & Optometry	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Myopia	en_US
dc.subject.mesh	Risk Factors	en_US
dc.subject.mesh	Evidence-Based Medicine	en_US
dc.subject.mesh	Internationality	en_US
dc.subject.mesh	Informed Consent	en_US
dc.subject.mesh	Practice Guidelines as Topic	en_US
dc.subject.mesh	Off-Label Use	en_US
dc.title	IMI – Clinical management guidelines report	en_US
dc.type	Journal Article
utslib.citation.volume	60	en_US
utslib.for	1113 Opthalmology and Optometry	en_US
utslib.for	06 Biological Sciences	en_US
utslib.for	11 Medical and Health Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	open_access
pubs.publication-status	Published	en_US
pubs.volume	60	en_US

Abstract:

© 2019 The Authors. Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/135444